Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

NatWest looking to offload workplace pensions provider Cushon - report

(Sharecast News) - NatWest is reportedly looking to offload Cushon, the workplace pensions provider it bought only two years ago. According to Sky News, NatWest is working with advisers on a sale of Cushon, for which it paid £144m in exchange for a controlling stake.

City sources told Sky the bank was in detailed talks with a number of potential buyers of the business.

Cushon offers workplace pension products as well as a range of workplace ISAs, including Junior ISAs, Lifetime ISAs and General Investment Accounts.

NatWest's acquisition of the business was aimed at diversifying its non-interest income by offering Cushon's products to the bank's commercial and business banking customers.

Cushon serves roughly 650,000 members across approximately 21,000 employers.

Its master trust offering has close to £3bn of assets under management and administration, with £17.4m in revenue generated from this area last year - 97% of Cushon's total revenues, Sky said.

NatWest owns an 85% stake in Cushon, with the remainder held by the subsidiary's management.

A market source told Sky that Cushon had drawn interest from a significant number of strategic players in the pensions market amid a growing push for consolidation.

A NatWest Group spokesperson told Sky: "We do not comment on speculation.

"Our focus remains on delivering for our customers."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.